SLQT - SelectQuote Inc Dividends
This article provides comprehensive financial data for SelectQuote Inc. (SLQT), including its stock performance, market capitalization, income, sales, and various financial ratios. It also lists key statistics such as EPS, sales growth, insider and institutional ownership, and profitability margins, highlighting that the company does not currently pay dividends.
Price to sales forward of SelectQuote, Inc. – NYSE:SLQT
This article provides the "Price to sales forward" financial metric for SelectQuote, Inc. (NYSE: SLQT). It lists the company's ticker, exchange, and highlights that the specified financial data is provided by ICE Data Services and FactSet. The content is presented within the context of TradingView's platform.
SLQT Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for SelectQuote, Inc. (SLQT), including analyst ratings, historical stock performance, and financial data. It indicates a current price of $0.8237 USD and a one-year price target ranging from $1.25 to $5.00 based on analyst opinions. The company's financials for the last quarter and upcoming earnings report are also detailed.
SelectQuote Inc Actuals & Estimates (NYSE:SLQT)
This article provides an overview of SelectQuote, Inc. (NYSE: SLQT) stock, including its current price, historical performance, and analyst forecasts. It details financial actuals and estimates for the income statement, balance sheet, and cash flow, along with key metrics like market capitalization and EBITDA. The report also covers upcoming earnings dates, past earnings performance, revenue figures, and employee count.
Price to earnings forward of SelectQuote, Inc. – NYSE:SLQT
This article displays the "Price to earnings forward" metric for SelectQuote, Inc. (NYSE:SLQT) on TradingView. It shows that there are no current values or changes available for this specific financial data point. The page structure includes market data, financial overviews, and other TradingView product features.
Enterprise value to EBIT forward of SelectQuote Inc – MUN:6SJA
This article provides financial data for SelectQuote Inc (MUN:6SJA) on TradingView, specifically focusing on its enterprise value to EBIT forward. It indicates that current market data for this particular metric is unavailable. The page serves as a financial overview for the company on the Munich Stock Exchange.
SelectQuote Inc (SLQT) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for SelectQuote Inc (SLQT), highlighting its current valuation score of 9.47, which ranks 5 out of 117 in the Insurance industry. It details the company's current P/E ratio of 7.72, noting its significant deviation from recent highs and lows. The report also indicates that P/B, P/S, and P/CF data have not yet been disclosed by the company.
Enterprise value to revenue forward of SelectQuote, Inc. – NYSE:SLQT
This article focuses on the "Enterprise value to revenue forward" metric for SelectQuote, Inc. (NYSE: SLQT). It provides a snapshot of this specific financial ratio for the company, accessible through the TradingView platform. The content is primarily a data point presentation rather than an analytical piece.
Price to earnings forward of SelectQuote Inc – MUN:6SJA
This page provides information about the "Price to earnings forward" for SelectQuote Inc (MUN:6SJA) on the Munich Stock Exchange. It indicates that the market is currently closed with no trades. The content also features typical navigation and footer elements found on financial data websites.
Enterprise value to EBIT forward of SelectQuote, Inc. – NYSE:SLQT
This article provides the enterprise value to EBIT forward for SelectQuote, Inc. (NYSE: SLQT). It appears to be a financial data point presented without further analysis or contextual information. The page is from TradingView and focuses on the company's financial metrics.
SLQT Financials: Revenue Breakdown, Margins & Competitor Comparison
This article analyzes SelectQuote Inc.'s (SLQT) financial performance, highlighting its revenue streams, profitability margins, and market positioning. Pharmacy revenue is the largest contributor at 66.5% of total sales, equivalent to $218.54M. The company also boasts a gross margin of 40.93% and is benchmarked against competitors like JRVR and AIFU within the Multiline Insurance & Brokers industry.
SelectQuote Inc (SLQT) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of SelectQuote Inc (SLQT), detailing its current price momentum score, trading range, and technical indicators. It identifies support at $0.77 and resistance at $1.11, suggesting suitability for range-bound swing trading. The analysis also summarizes various technical indicators and moving averages, with a current overall signal of "Sell."
SelectQuote Inc (SLQT) Institutional Confidence
SelectQuote Inc (SLQT) has an institutional shareholding score of 5.00, placing it 74th out of 118 in the Insurance industry. The institutional shareholding proportion is 55.78%, showing a 4.68% increase quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.58% of shares outstanding.
SelectQuote Inc (SLQT) Earnings Forecast: Future EPS & Revenue Growth Estimates
SelectQuote Inc (SLQT) has an earnings forecast score of 7.00, ranking 56th in the Insurance industry, with an average price target of $4.50. Analysts generally recommend a "Buy" for SLQT, predicting an upside of over 200%. The company expects Q2 revenue of $353.44M and Q1 EPS of $0.27, with an anticipated EPS of -$0.16 for the next quarter.
SelectQuote Inc (SLQT) Financial Health: Profitability & Balance Sheet Analysis
SelectQuote Inc (SLQT) currently holds a financial score of 7.40, placing it 40th out of 117 in the Insurance industry, indicating stable financial health and average operating efficiency. The company recently reported a quarterly revenue of $430.93 million, marking a 5.58% year-over-year increase, with net profit also rising by 5.87% year-over-year. The financial analysis provided by TradingKey includes detailed scores for various financial dimensions, although specific data for cash, assets, liabilities, and profits have not been fully disclosed for some categories.
SelectQuote Inc (SLQT) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of SelectQuote Inc (SLQT) stock, focusing on its dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years and has no recorded stock split data. The page displays current stock price, market cap, and P/E ratio, indicating an absence of recent payout events.
SelectQuote Inc (SLQT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for SelectQuote Inc (SLQT), detailing its business segments and regional revenue contributions. As of June 17, 2024, the company's revenue is primarily driven by commissions (50.54%) and pharmacy revenue (42.30%), with all revenue generated from the United States. The market capitalization for SelectQuote Inc stands at $178.04 million with a P/E TTM of 9.46.
New Strong Buy Stocks for June 15th
Zacks Equity Research has identified five new stocks as "Strong Buys" for June 15th, based on significant increases in their current-year earnings estimates over the past 60 days. These companies include SelectQuote, EZCORP, Douglas Dynamics, nVent Electric, and Alto Ingredients, all showing favorable analyst consensus. Investors can access a complete list of Zacks' #1 Rank (Strong Buy) stocks and additional recommendations.
SLQT Technical Analysis & Stock Price Forecast
This article provides a technical analysis and stock price forecast for SelectQuote Inc (SLQT), indicating a "Strong Sell" consensus based on various technical indicators and moving averages. Key metrics like MACD, RSI, and moving averages are analyzed, alongside support and resistance levels. The stock is currently trading below its 200-day moving average, suggesting a bearish long-term trend.
SelectQuote Company Profile & Introduction
This document provides a company profile and introduction for SelectQuote. It serves as an informative overview for those seeking to understand the company's background and operations.
NY-based Medicare firm Chapter will expand hiring in KC
New York-based Medicare advising company Chapter plans to hire 50 new employees in Kansas City over the next year. The company views Kansas City as a strategic talent hub due to the presence of experienced Medicare agents from rival firms. This expansion highlights Chapter's focus on growing its operations in key regional markets.
SelectQuote(SLQT) Stock Options Chain | Quotes & News
The article provides a stock options chain for SelectQuote (SLQT), including quotes and news. It is a financial data page focused on derivatives trading information for the company.
SelectQuote Inc. Highlights Progress Amid Policy Headwinds
SelectQuote Inc. reported a 6% year-over-year increase in consolidated revenue and an 18% rise in adjusted EBITDA for Q3, driven by strong performance in its Senior and Healthcare Services segments. The company highlighted its nearly $1 billion Medicare Advantage commissions receivable and progress with SelectRx, despite facing headwinds from the Inflation Reduction Act and PBM reimbursement actions. Management maintained its fiscal 2026 guidance, expressing confidence in future cash flow generation and value creation.
Insider Sell: Denise Devine Sells 4,000 Shares of SelectQuote In
Denise Devine, a Director at SelectQuote Inc (SLQT), sold 4,000 shares of the company on May 19, 2026. Following this transaction, Devine owns 367,214 shares. The stock is currently trading at $1.02, indicating it might be a "Possible Value Trap" according to GuruFocus's GF Value of $2.20.
[Form 4] SelectQuote, Inc. Insider Trading Activity
SelectQuote, Inc. director Denise L. Devine reported an open-market sale of 4,000 shares of common stock on May 19, 2026, at an average price of $1.02 per share. Following this transaction, Devine directly holds 367,214 shares of SelectQuote common stock. This insider trading activity was filed as a Form 4, indicating a net sale of $4,080.
[144] SelectQuote, Inc. SEC Filing
This SEC filing for SelectQuote, Inc. (SLQT) is a Form 144 Notice of Proposed Sale of Securities pursuant to Rule 144. It details the proposed sale of 4000 shares of common stock by an unnamed person through Morgan Stanley Smith Barney LLC on May 19, 2026, with an aggregate market value of $4240.00. The shares were acquired via an open market purchase on May 21, 2020.
SelectQuote Announces Participation in Upcoming RBC Global Healthcare Conference on May 20
SelectQuote, Inc. announced that its CFO, Ryan Clement, and Head of Investor Relations, Matt Gunter, will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on May 20, 2026, at approximately 11:00 am ET. Management will also be available for investor meetings. The company, a leading distributor of Medicare insurance policies and owner of a growing healthcare services platform, will discuss its business and financial updates.
SelectQuote Q3 FY2026 slides: EBITDA surges 18% on Senior strength
SelectQuote (NYSE:SLQT) reported a strong fiscal third quarter of 2026, with adjusted EBITDA surging 18% year-over-year to $45 million and consolidated revenue increasing 6% to $431 million. The company's stock jumped significantly after the earnings release, driven by robust profitability and an impressive 450% earnings surprise in net income per share. The Senior division was a key performer, with its adjusted EBITDA up 28%, alongside significant improvements in operational efficiency and growth in the Healthcare Services segment.
SelectQuote Q3 FY2026 slides: EBITDA surges 18% on Senior strength
SelectQuote (NYSE:SLQT) reported strong Q3 FY2026 earnings, with adjusted EBITDA surging 18% to $45 million on $431 million in revenue. The company's Senior segment was a key driver, achieving an 8% revenue increase and 28% adjusted EBITDA growth, contributing significantly to a 450% earnings surprise. Operational efficiencies, including increased agent productivity and reduced marketing expenses, also played a crucial role in the improved profitability and investor confidence.
Zacks Research Upgrades SelectQuote (NYSE:SLQT) to Strong-Buy
Zacks Research has upgraded SelectQuote (NYSE:SLQT) from a "hold" to a "strong-buy" rating, indicating an improving analyst outlook for the company. Despite mixed analyst ratings, the stock holds a "Moderate Buy" consensus and an average target price of $2.92. SelectQuote recently surpassed quarterly EPS expectations, reporting $0.15 against an anticipated loss of $0.02, though revenue slightly missed estimates.
SelectQuote reaffirms fiscal 2026 outlook of $1.61B-$1.71B revenue and $90M-$100M adjusted EBITDA, while targeting SelectRx $40M-$50M run rate
SelectQuote (NYSE: SLQT) has reaffirmed its financial guidance for fiscal year 2026, projecting revenue between $1.61 billion and $1.71 billion and adjusted EBITDA of $90 million to $100 million. Additionally, the company is targeting a run rate of $40 million to $50 million for its SelectRx segment. This outlook provides investors with an updated long-term financial perspective for the company.
SelectQuote, Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:SLQT) 2026-05-07
SelectQuote, Inc. (NYSE:SLQT) published its Q3 2026 earnings call presentation, reporting an EPS of $0.04, beating estimates by $0.02. The company's revenue for the quarter was $430.93M, representing a 5.58% year-over-year increase, but missing analyst estimates by $7.99M. This report provides the slide deck used during the earnings call.
Earnings call transcript: SelectQuote Q3 2026 beats EPS expectations
SelectQuote Inc. (SLQT) reported strong Q3 2026 earnings, with EPS of $0.11 significantly beating the forecasted $0.02, leading to a 21.7% surge in premarket trading. Despite revenue slightly missing expectations at $431 million, the company highlighted robust growth in its Senior and Healthcare Services segments. SelectQuote reaffirmed its fiscal 2026 outlook and expressed confidence in future cash flow growth, aiming to address the disconnect in its equity valuation.
SelectQuote, Inc. (NYSE:SLQT) Given Average Recommendation of "Moderate Buy" by Brokerages
SelectQuote, Inc. (NYSE:SLQT) has an average "Moderate Buy" rating from five analysts, with a 1-year price target of approximately $2.92. Despite revenue slightly missing forecasts, the company reported an EPS beat of $0.15 against estimates of ($0.02). Analyst opinions are varied, with some downgrading and others upgrading the stock, while institutional ownership stands at around 34.6%.
SelectQuote (SLQT) Returns To Quarterly Profit But Volatile EPS Tests Bullish Margin Story
SelectQuote (SLQT) reported a profitable Q2 2026 with total revenue of US$537.1 million and net income of US$51.2 million, translating to basic EPS of US$0.27. While bulls highlight potential for higher EBITDA margins and recurring healthcare revenue, the company's EPS has been volatile with a mix of profits and losses in previous quarters. Analysts forecast a decline in earnings despite a seemingly low P/E ratio, raising concerns about the sustainability of its current profit levels and its ability to cover interest payments.
SelectQuote reaffirms fiscal 2026 outlook of $1.61B-$1.71B revenue and $90M-$100M adjusted EBITDA, while targeting SelectRx $40M-$50M run rate
SelectQuote has reaffirmed its financial outlook for fiscal year 2026, projecting revenue between $1.61 billion and $1.71 billion and adjusted EBITDA of $90 million to $100 million. Additionally, the company is targeting a run rate for its SelectRx segment of $40 million to $50 million. This announcement indicates the company's continued confidence in its long-term financial performance and strategic initiatives.
SelectQuote posts higher Q3 revenue amid Medicare shifts
SelectQuote, Inc. reported increased revenue and net income for the third quarter of fiscal year 2026, driven by operational steadiness despite shifts in the Medicare Advantage and prescription drug markets. The company achieved consolidated revenue of $430.9 million and a net income of $40.2 million, reaffirming its financial outlook for fiscal 2026. Growth was noted in its Senior division and SelectRx pharmacy business, which are positioned for future cash flow expansion.
SelectQuote, Inc. (NYSE:SLQT) Q3 2026 Earnings Call Transcript
SelectQuote, Inc. (NYSE: SLQT) reported strong financial results for Q3 2026, exceeding earnings expectations with an EPS of $0.11 against an expected $-0.02. The company reaffirmed its fiscal 2026 outlook, driven by solid performance across its Senior, Healthcare Services, and Life Insurance segments, and highlighted its success in expanding cash flow and enhancing operational efficiencies. CEO Tim Danker and CFO Ryan Clement discussed strategic initiatives like SelectQuote Local and positive adjustments to commissions receivable, while addressing the disconnect between the company's valuation and its intrinsic value.
SelectQuote (NYSE:SLQT) Stock Forecast & Analyst Predictions
SelectQuote (NYSE:SLQT) is forecast to experience a decline in earnings at 21.5% per annum, despite an expected annual revenue growth of 4.8%. The company recently reaffirmed its earnings guidance for fiscal year 2026, projecting revenue between $1.61 billion and $1.71 billion. Analyst price targets have generally been trimmed, and the stock faces major risks including highly volatile share price, declining earnings forecasts, and a notice of non-compliance with NYSE listing standards due to its average closing price falling below $1.00.
SelectQuote downgraded by Credit Suisse with a new price target
SelectQuote (SLQT) has been downgraded by Credit Suisse, which also set a new price target for the company. This update is part of Credit Suisse's recent analyst ratings on SelectQuote, following other analyst actions earlier in the year. The article also provides recent SEC filings and press releases related to SelectQuote's financial performance and operational updates.
SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results
SelectQuote, Inc. reported strong third-quarter fiscal year 2026 results, with consolidated revenue reaching $430.9 million and net income climbing to $40.2 million. The company reaffirmed its fiscal year 2026 guidance, expecting revenue between $1.61 billion and $1.71 billion, and Adjusted EBITDA between $90 million and $100 million. CEO Tim Danker highlighted consistent profit and cash flow despite market shifts, driven by operational execution and the growing SelectRx business.
Earnings call transcript: SelectQuote Q3 2026 beats EPS expectations
SelectQuote Inc. (SLQT) reported strong Q3 2026 earnings, beating EPS expectations with $0.11 against a forecast of $0.02, leading to a 21.7% surge in premarket trading despite revenue falling slightly short at $431 million. The company highlighted robust growth in its Senior and Healthcare Services segments and an 18% increase in Adjusted EBITDA, reaffirming its fiscal year 2026 outlook. Management expressed confidence in future cash flow generation and the company's strategic initiatives, including a new "SelectQuote Local" franchise model, while actively addressing the disconnect in its equity valuation.
SelectQuote reports Q3 FY2026 revenue $430.9M, net income $40.2M, Adjusted EBITDA $44.6M
SelectQuote announced its financial results for the third quarter of fiscal year 2026, reporting consolidated revenue of $430.9 million, net income of $40.2 million, and Adjusted EBITDA of $44.6 million. The company reiterated its fiscal 2026 guidance, projecting revenue between $1.61 billion and $1.71 billion and Adjusted EBITDA between $90 million and $100 million. Key highlights included growth in Healthcare Services membership and increased commissions receivable, indicating strong future cash flow potential.
SelectQuote: Fiscal Q3 Earnings Snapshot
SelectQuote, Inc. (SLQT) reported a profit of $40.2 million in its fiscal third quarter, resulting in a net income of 11 cents per share. Adjusted earnings were 15 cents per share, and the company posted revenue of $430.9 million. SelectQuote anticipates full-year revenue to be between $1.61 billion and $1.71 billion.
SelectQuote, Inc. Reports Third Quarter of Fiscal Year 2026 Results
SelectQuote, Inc. (NYSE: SLQT) announced its third-quarter fiscal year 2026 results, reporting consolidated revenue of $430.9 million, net income of $40.2 million, and Adjusted EBITDA of $44.6 million. The company reaffirmed its fiscal year 2026 guidance, expecting revenue between $1.61 billion and $1.71 billion and Adjusted EBITDA between $90 million and $100 million. CEO Tim Danker highlighted consistent profit and cash flow, driven by operational execution and the strong performance of its healthcare services model, noting a high 6.7X revenue to customer acquisition cost multiple.
Q2 2026 SelectQuote Inc Earnings Call Transcript
SelectQuote Inc. (SLQT) reported a strong second quarter for fiscal 2026, with a 12% year-over-year revenue increase to $537 million, primarily driven by strong performance in its senior segment and a 26% revenue increase in Select RX. However, the company lowered its full fiscal year 2026 guidance by $40 million due to marketing budget cuts from a national carrier and changes in PBM reimbursement policies, which are expected to create a $20 million headwind to EBITDA. Despite these challenges, SLQT secured a new $415 million credit facility, improving its capital flexibility and extending debt maturities to 2031, while also maintaining a 33% policyholder recapture rate.
SelectQuote (SLQT) Q2 2025 earnings summary
SelectQuote (SLQT) reported strong Q2 FY25 results with a 19% year-over-year revenue growth to $481.1M and a 30% increase in Adjusted EBITDA to $87.5M, driven by its Senior and Healthcare Services segments. The company raised its FY25 guidance for revenue, Adjusted EBITDA, and net income, reflecting robust operational performance. Strategic financial moves, including a $350M preferred equity investment and a $100M securitization, have improved liquidity and capital structure.
SelectQuote (SLQT) Projected to Post Quarterly Earnings on Tuesday
SelectQuote (SLQT) is projected to announce its Q3 2026 earnings before market open on Tuesday, May 5th, with analysts expecting an EPS of ($0.02) and revenue of $438.93 million. The company beat estimates in the last quarter but analysts now forecast $0 EPS for the current and next fiscal years, assigning a "Hold" rating with a consensus target price of $2.92. Recent trading saw SLQT stock up 7.6% to $0.99, and institutional ownership stands at approximately 34.6%.
Follow the Trend Seeker: Beaten-Down SelectQuote Stock Surges 54% in 1 Month as Barchart’s Data Signals ‘Buy’
SelectQuote (SLQT) stock has surged 54% in the last month after Barchart's Trend Seeker issued a "Buy" signal on April 17, despite a 72% loss over the past year. Analysts project significant earnings growth for next year, though current Wall Street sentiment is mixed. The article suggests SLQT as a speculative rebound candidate for investors looking for beaten-down stocks starting to recover.
SelectQuote Secures New $415 Million Credit Facility Comprised of $325 Million Term Loan with Pathlight Capital Alongside $90 Million Revolving Credit Facility with UMB Bank
SelectQuote, Inc. (NYSE: SLQT) has secured a new $415 million credit facility, consisting of a $325 million term loan from Pathlight Capital and a $90 million revolving credit facility from UMB Bank. This agreement significantly extends their debt maturity to 2031, enhances liquidity, and improves the cost of capital. The company states this financing strengthens its financial position and supports future growth, particularly for its senior health insurance and healthcare services businesses.
